Triad Japan Co., Ltd. to Establish New Pharmaceutical Development Division Office in Nihombashi-Kayabacho, Tokyo, in Line with Business Expansion

Triad Japan Co., Ltd., a company supporting the realization of new medical treatments through clinical trial implementation assistance (Tokyo Office: Shibuya-ku, Tokyo; Representative Director: Mihoko Goto; hereinafter “Triad Japan”), announces the establishment of a new Pharmaceutical Development Division office in Nihombashi-Kayabacho in August 2026, in line with business expansion and organizational strengthening.

Turning Change into Momentum for the Next Stage

Amid growing expectations for new medical treatments, Triad Japan, as a Site Management Organization (SMO) supporting medical advancement through clinical trials, is working to build a higher-quality and more flexible support system. The establishment of the new Pharmaceutical Development Division office is part of environmental enhancements aimed at business expansion and organizational growth, marking a new challenge toward the next phase of growth for the company.

The Nihombashi area, the new location, is a key hub in the life sciences sector, where numerous pharmaceutical and healthcare-related companies are concentrated. By relocating to this area, Triad Japan aims to further strengthen collaboration with diverse partners, including medical institutions and pharmaceutical companies, and build a system capable of smoothly supporting an increasing number of clinical trials.

The company will also focus on creating an environment where each employee can confidently utilize their abilities, thereby strengthening the organizational foundation necessary for sustainable growth. By transforming change into a positive force, Triad Japan will continue to pursue new value creation and contribute to the advancement of the healthcare industry and the realization of new medical treatments.

Features of the New Office

Designed under the theme of "Returnable Place," the office features warm materials and color schemes that naturally integrate "interaction" and "concentration."

The office includes a free-address workspace, a café area to encourage casual communication, and a multipurpose lounge space. These spaces are designed to accommodate various purposes, such as focused work and meetings. The lounge space can also host events and networking gatherings of up to approximately 80 people in a standing format.

The office environment is designed to be open and creative, fostering not only stronger connections among employees but also interactions with external partners and the creation of new forms of communication. By balancing ease of work with an environment that encourages challenges, the company aims to promote overall organizational growth and new collaborations and co-creation initiatives.

Overview of the New Office

Location

7th Floor, JRE Kayabacho Nichome Building, 2-13-13 Nihombashi-Kayabacho, Chuo-ku, Tokyo

Access

1-minute walk from Kayabacho Station on the Tokyo Metro Tozai Line / Hibiya Line

Start of Operations

Scheduled for Monday, August 10, 2026

About Triad Japan Co., Ltd.

Triad Japan supports people's health and the development of future pharmaceuticals, primarily through its clinical trial operations (SMO business) and insurance pharmacy business (Kamome Pharmacy). In particular, its SMO business has supported over 100 medical institutions in psychiatric and neurological fields. Currently, the company provides broad support to medical institutions and pharmaceutical companies across all therapeutic areas, ensuring clinical trials are conducted properly and efficiently. In addition to Clinical Research Coordinator (CRC) services, the company has established a comprehensive support system including administrative support, psychological evaluator dispatch, and clinical trial participant recruitment, and collaborates with numerous medical institutions.

Company Name: Triad Japan Co., Ltd.

Headquarters: 3-14-20 Sagamidai, Minami-ku, Sagamihara, Kanagawa

Tokyo Office: 4-26-11 Sendagaya, Shibuya-ku, Tokyo

Established: December 22, 1995

Representative: Representative Director Mihoko Goto

Business Activities: Clinical trial support, psychological evaluator dispatch, clinical trial participant recruitment, insurance pharmacy business, and others

URL: https://www.triad-j.co.jp/